148 related articles for article (PubMed ID: 6117380)
1. Hemodynamic effects of atrial pacing and prenalterol infusion in patients taking beta-adrenergic blocking drugs.
Shiu MF; Ireland MA; Littler WA
Circulation; 1981 Dec; 64(6):1135-41. PubMed ID: 6117380
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
[TBL] [Abstract][Full Text] [Related]
3. The immediate haemodynamic and electrophysiological response to prenalterol during fixed rate pacing in patients with chronic ischaemic heart disease.
Sire S; Amlie JP; Simonsen S
Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):43-8. PubMed ID: 3953293
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
Klein W; Brandt D; Maurer E
Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of prenalterol in patients with coronary heart disease.
Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
[TBL] [Abstract][Full Text] [Related]
6. [Effects of Prenalterol on left ventricular function of coronary patients].
Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
[TBL] [Abstract][Full Text] [Related]
7. Prenalterol in primary dilated cardiomyopathy: hemodynamic and angiographic evaluation.
Branzi A; Specchia S; Binetti G; Magelli C; Zannoli R; Magnani B
Eur Heart J; 1983 Apr; 4(4):252-8. PubMed ID: 6684041
[TBL] [Abstract][Full Text] [Related]
8. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
Manders WT; Vatner SF; Braunwald E
J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
[TBL] [Abstract][Full Text] [Related]
9. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
[TBL] [Abstract][Full Text] [Related]
10. The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease.
Muir AL; Hannan WJ; Dewhurst NG; Slessor IM
Br J Clin Pharmacol; 1981 Oct; 12(4):475-80. PubMed ID: 7295483
[TBL] [Abstract][Full Text] [Related]
11. The hemodynamic actions of prenalterol in left ventricular failure.
Awan NA; Evenson MK; Needham KE; Mason DT
Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
[TBL] [Abstract][Full Text] [Related]
12. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
Wirtzfeld A; Klein G; Bibra HV; Sauer E
Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
[TBL] [Abstract][Full Text] [Related]
13. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
[TBL] [Abstract][Full Text] [Related]
14. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
Kupper W; Schütt M; Bleifeld W
Acta Med Scand Suppl; 1982; 659():287-98. PubMed ID: 6127895
[TBL] [Abstract][Full Text] [Related]
15. [Prenalterol (CGP 7760 B), a new cardioselective beta 1-adrenoceptor-agonist (author's transl)].
Piepenbrock S; Reichelt W; Zenz M; Seitz W; Sikalieh E
Anaesthesist; 1981 Mar; 30(3):118-23. PubMed ID: 6111933
[TBL] [Abstract][Full Text] [Related]
16. Influence of heart rate on the effects of prenalterol on regional myocardial blood flow and function during coronary stenosis in dogs.
Berdeaux A; Bonhenry C; Duhazé P; Giudicelli JF; Thuillez C
Br J Pharmacol; 1984 Sep; 83(1):203-10. PubMed ID: 6148979
[TBL] [Abstract][Full Text] [Related]
17. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
[TBL] [Abstract][Full Text] [Related]
18. Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure.
Pedersen T; Cleemann-Rasmussen K; Brynjolf I; Ording H; Nielsen PE; Rasmussen K
Eur J Clin Pharmacol; 1983; 25(3):287-92. PubMed ID: 6628515
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.
Erbel R; Meyer J; Lambertz H; Schweizer P; Voelker W; Krebs W; Braun G; Effert S
Circulation; 1982 Aug; 66(2):361-9. PubMed ID: 6124326
[No Abstract] [Full Text] [Related]
20. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
Currie PJ; Kelly MJ; Middlebrook K; Federman J; Sainsbury E; Ashley J; Pitt A
Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
